Corporate partnerships aiding cancer vaccine development.
Thompson
T
T
D015295:Antigens, Tumor-Associated, Carbohydrate / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D002170:Canada; D019496:Cancer Vaccines / Q000627:therapeutic use*; D017326:Clinical Trials, Phase III as Topic; D004345:Drug Industry; D005260:Female; D006433:Hemocyanins / Q000627:therapeutic use*; D006801:Humans; D015337:Multicenter Studies as Topic
D015295:Antigens, Tumor-Associated, Carbohydrate; D019496:Cancer Vaccines; C099077:sialyl-Tn antigen-keyhole-limpet hemocyanin conjugate; D006433:Hemocyanins